Not Yet Recruiting NA INTERVENTIONAL 1-arm
NCT07290998
Treatment of Locally Recurrent Prostate Cancer
A Safety Study of Intratumoral Diffusing Alpha Radiation Emitters for the Treatment of Locally Recurrent Prostate Cancer
Sponsor: Alpha Tau Medical LTD.
Updated 1 time since 2026 Last updated: Dec 17, 2025 Started: May 31, 2026 Primary completion: May 31, 2028 Completion: May 31, 2029
This information is for research purposes only and is not medical advice. Consult a healthcare provider before making any medical decision.
Listed as NCT07290998, this NA trial focuses on Locally Recurrent Prostate Cancer and Prostate Cancer and remains actively recruiting participants. Sponsored by Alpha Tau Medical LTD., it has been updated 1 time since 2026, reflecting limited change activity. This study contributes to the evolving evidence base for cancer treatment protocols.
Status Flow
Change History
1 version recorded Not Yet Recruiting — NA
[monthly]
Eligibility Summary
No eligibility information available.
Contact Information
Sponsor contact:
- Alpha Tau Medical LTD.
Data source: Alpha Tau Medical LTD.
For direct contact, visit the study record on ClinicalTrials.gov .
Study Locations
No location information available.